Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 40 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.11M 9,053 sh | Apr 24, 2026 |
| 40 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.36M 11.0K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 37 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $277K 2,264 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 37 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $341K 2,759 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 36 | Girao TiagoChief Financial Officer |  IMVTImmunovant, Inc.Open-market sale | SELL | $763K 25.8K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 35 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $9,994 80 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 35 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2,499 20 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $647K 5,384 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $606K 5,120 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $894K 7,496 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $152K 1,280 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $162K 1,346 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $224K 1,874 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 29 | Golten Alex SCHIEF RISK OFFICER |  GSGOLDMAN SACHS GROUP INCOpen-market sale | SELL | $501K 535 sh | Apr 24, 2026 traded Apr 23, 2026 |
| 29 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $262K 2,160 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 29 | Golten Alex SCHIEF RISK OFFICER | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $544K 581 sh | Apr 24, 2026 traded Apr 23, 2026 |
| 28 | Reid Jeffrey A.EVP, Chief HR Officer |  BOKFBOK FINANCIAL CORPOpen-market sale | SELL | $148K 1,095 sh | Apr 24, 2026 traded Apr 23, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $66K 540 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 25 | Stout Jay SChief Technology Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $82K 2,754 sh | Apr 24, 2026 traded Apr 23, 2026 |
| 21 | Reid Jeffrey A.EVP, Chief HR Officer | BOKFBOK FINANCIAL CORP Open-market sale | SELL | $14K 105 sh | Apr 24, 2026 traded Apr 23, 2026 |
| 19 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $269K 19.1K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 14 | Patel Rahul G.Director, See remarks below |  SYNASYNAPTICS IncOpen-market sale · 10b5-1 plan | SELL | $205K 2,281 sh | Apr 24, 2026 traded Apr 24, 2026 |
| 11 | Hamilton James CChief Medical Officer |  ARWRARROWHEAD PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $750K 10.0K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 9 | McDonough ClaireChief Financial Officer |  RIVNRivian Automotive, Inc. / DEOpen-market sale · 10b5-1 plan | SELL | $184K 10.2K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 6 | Gibson ChristopherDirector |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $144K 40.0K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $262K 19.1K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $267K 19.1K sh | Apr 24, 2026 traded Apr 24, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $31K 10.0K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer | LAESSEALSQ Corp Open-market sale · 10b5-1 plan | SELL | $15K 5,250 sh | Apr 24, 2026 traded Apr 24, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer | LAESSEALSQ Corp Open-market sale · 10b5-1 plan | SELL | $29K 10.0K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 44 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.43M 12.1K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 43 | Sharma SanjaySee Remarks* |  SEICSEI INVESTMENTS COOpen-market sale | SELL | $2.11M 23.4K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 41 | Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER |  SGMOSANGAMO THERAPEUTICS, INCOpen-market sale | SELL | $89K 345.9K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 41 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $388K 3,255 sh | Apr 23, 2026 traded Apr 21, 2026 |
| 40 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $5.66M 49.0K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 40 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.57M 22.1K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 40 | Peterson MichaelEXECUTIVE VICE PRESIDENT | SEICSEI INVESTMENTS CO Open-market sale | SELL | $900K 10.0K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 40 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.83M 15.5K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 39 | Patrick Deval LDirector |  TOSTToast, Inc.Open-market sale | SELL | $62K 1,667 sh | Apr 23, 2026 traded Jan 9, 2025 |
| 35 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $10.51M 90.9K sh | Apr 23, 2026 traded Apr 21, 2026 |